CP-316819 | m-entrepreneurship.com

Product Name :
CP-316819

Search keywords :
CP-316819

drugId :
null

Target Vo:
Glycogen phosphorylase

Target Vo Short Name :
PYG

Moa_Name:
Glycogen phosphorylase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Diabetes Mellitus, Type 2

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
GSK3 beta Antibody (YA397)
Casein Kinase 2 beta Antibody
VGluT1 Antibody: VGluT1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 62 kDa. It can be used for WB assays in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts